Wordt geladen...
miR-181 regulation of BAX controls cisplatin sensitivity of prostate cancer cells
Prostate cancer is one of the most common male malignancies and remains the second leading cause for cancer-specific mortalities in men. Cisplatin is commonly used as a chemotherapeutic agent against advanced cancers, and is now used in metastatic prostate cancers. Cisplatin exerts its cytotoxic eff...
Bewaard in:
| Gepubliceerd in: | Int J Clin Exp Pathol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
e-Century Publishing Corporation
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966011/ https://ncbi.nlm.nih.gov/pubmed/31966904 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|